Cargando…
Rapamycin Is Neuroprotective in a Rat Chronic Hypertensive Glaucoma Model
Glaucoma is a leading cause of irreversible blindness. Injury of retinal ganglion cells (RGCs) accounts for visual impairment of glaucoma. Here, we report rapamycin protects RGCs from death in experimental glaucoma model and the underlying mechanisms. Our results showed that treatment with rapamycin...
Autores principales: | Su, Wenru, Li, Zuohong, Jia, Yu, Zhuo, Yehong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4055719/ https://www.ncbi.nlm.nih.gov/pubmed/24923557 http://dx.doi.org/10.1371/journal.pone.0099719 |
Ejemplares similares
-
Correction: Rapamycin Is Neuroprotective in a Rat Chronic Hypertensive Glaucoma Model
por: Su, Wenru, et al.
Publicado: (2019) -
Corrigendum to ‘microRNA-21a-5p/PDCD4 axis regulates mesenchymal stem cell-induced neuroprotection in acute glaucoma’
por: Su, Wenru, et al.
Publicado: (2023) -
Clinical Outcomes of FP-7/8 Ahmed Glaucoma Valves in the Management of Refractory Glaucoma in the Mainland Chinese Population
por: Zhu, Yingting, et al.
Publicado: (2015) -
Laquinimod Inhibits Inflammation-Induced Angiogenesis in the Cornea
por: Li, Zuohong, et al.
Publicado: (2020) -
Disturbed glucose and pyruvate metabolism in glaucoma with neuroprotection by pyruvate or rapamycin
por: Harder, Jeffrey M., et al.
Publicado: (2020)